This is the authors' abstract. We don't add key points for this paper.
L-ASPARAGINASE affords a unique approach to the chemotherapy of malignant neoplasms by exploiting a metabolic difference between tumor cells and host cells.Historical BackgroundIn 1953 Kidd1 noted that normal guinea-pig serum has antitumor activity, and Broome2 subsequently showed that the active antitumor substance is L-asparaginase, which is present in high concentration in the serum of the guinea pig and its close relatives. Dolowy and his associates3 used purified guinea-pig serum to treat a boy with acute lymphoblastic leukemia and obtained an objective response. The discovery of Escherichia coli L-asparaginase with antitumor activity presented a source of enzyme in sufficient . . .
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Whitecar et al. (1970) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: